Clinician
Delivered direct patient care for roughly sixteen years. I know what documentation burden and prior-authorization friction feel like from the treatment room.
Twenty years across the full healthcare value chain: treating patients, owning a practice, running clinics, reviewing utilization, and leading enterprise health plan partnerships at the vice-president level. I translate clinical, operational, and financial complexity into decisions executives can act on.
I've treated patients, carried a revenue number, and negotiated contracts, building a working fluency in both clinical care and commercial strategy. That combination is what lets me build solutions that actually hold up for the patient, the provider, the payer, and the business at the same time.
Delivered direct patient care for roughly sixteen years. I know what documentation burden and prior-authorization friction feel like from the treatment room.
Founded a physical therapy clinic, grew it to about twenty employees, and sold it profitably. Payer contracting, revenue cycle, staffing, and margin were mine to solve.
Directed outpatient clinics and regional operations: budgets, hiring, productivity, clinical quality, and financial performance across locations.
Worked inside utilization management and clinical policy, which is where most payer–provider friction is actually created or resolved.
Led the work of reducing provider abrasion and untangling network, claims, and reimbursement issues on behalf of health plans and their networks.
Owned vice-president-level relationships with health plan presidents, CMOs, CFOs, COOs, and network and procurement leaders across Commercial, Medicare Advantage, Medicaid, and ASO.
eviCore by Evernorth is the largest prior authorization company in the U.S., supporting over 100 million patients annually across 100+ health plan partners.
Evolent Health (NYSE: EVH) is a publicly traded company with over $2.5B in annual revenue, managing specialty care for tens of millions of lives nationally.
Magellan Health was a Fortune 500 company (#390, 2021) with approximately $4.6B in annual revenue and 9,000+ employees, later acquired by Centene in 2022.
Turning strained, at-risk partnerships into stable and expanding ones, usually by fixing governance and accountability before touching the commercials.
Cost-of-care analysis, risk-based and delegated arrangements, capitated pricing, and performance commitments across all lines of business.
Retention, renewals, contracting, and expansion on complex multi-stakeholder accounts where the buying committee spans clinical, financial, and operational leadership.
Turning utilization data, clinical outcomes, and operational performance into a narrative an executive team can make a decision from.
Quarterbacking clinical, product, analytics, implementation, operations, finance, legal, and contracting teams toward a client commitment.
Reducing provider abrasion and administrative burden in specialty utilization management and medical benefit management.
Where the instinct came from, the frameworks I keep coming back to for rebuilding trust in relationships everyone else had already written off, and the occasional lesson from the volleyball court. Meant to be read in order. The series adds a new story every week.
Who I am, the diagnose-then-build instinct, and why I'm exploring what's next.
Read the story →
The kill shot gets remembered. The first touch is what actually won the point, three moves earlier.
Read the story →
You can measure a team in three seconds. Not the point they win, but what happens right after someone drops the ball.
Read the story →Organizations that value healthcare depth in strategic account leadership, where owning complex payer and provider relationships, and being credible with both clinicians and CFOs, is the point of the role.
Based in the Lake Norman area of North Carolina, near Charlotte. Strong preference for remote work, and open to travel where the opportunity warrants it.
If you're building a team where clinical credibility and commercial discipline have to coexist, I'd welcome the conversation.